Owner Novartis AG

Inventors Marzinzik, Andreas; Zimmermann, Johann; Mueller-Hartwieg, Constanze; Stauffer, Frederic; Amstutz, Rene; Ofner, Silvio; Cotesta, Simona; Jahnke, Wolfgang; Bold, Guido

Agent Davies Collison Cave

Pub. Number AU-A-2009218468

PCT Pub. Number WO2009/106586

Priority 08152046.2 28.02.08 EP

Filing date 26 February 2009

Wipo publication date 3 September 2009

C07D 215/48 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61P 35/04 (2006.01) Antineoplastic agents

C07D 215/18 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07F 9/60 (2006.01) Compounds containing elements of the 5th Group of the Periodic System